PRTN3 and rheumatoid arthritis: Other studies have shown that certain inflammatory markers, such as C-C motif chemokine ligand (CCL)13, CCL18, and MMP3 are upregulated in ACPA-negative patients with RA, suggesting a distinct inflammatory profile in this subset of the disease (27).